Other Clinical Trial - Human Papillomavirus Education Programs

Status Completed

Clinical Trial Summary

This clinical trial aims to implement a culturally-tailored educational outreach actives with the goal of increasing knowledge of human papillomavirus (HPV) types that can lead to cancer and uptake of the available vaccine. The initiative also addresses barriers to vaccination and refer people to sites where they can get the HPV vaccine (e.g., private doctor offices, community health clinics, school-based health centers, and health departments). The HPV education program may help increase HPV vaccination rates and ultimately prevent HPV-related cancers.

Clinical Trial Description

PRIMARY OBJECTIVE: I. To implement culturally tailored educational outreach activities with the goal of increasing knowledge of HPV types that can lead to cancer and uptake of the available vaccine. OUTLINE: Participants attend educational session about HPV-related cancers, screening, and HPV vaccination and guidelines and receive informational infographic handout on HPV vaccination. Participants also complete surveys pre and post education session over 5 minutes each to assess HPV vaccination status among children of participants, HPV knowledge, and intentions to get the HPV vaccination, and screening among participants. Participants participate in surveys over telephone or face-to-face at 3 and 6 months. ;

Study Design

Related Conditions & MeSH terms

Human Papillomavirus-Related Carcinoma

Clinical Trial Details

NCT number	NCT04880837
Study type	Interventional
Source	Ohio State University Comprehensive Cancer Center
Contact
Status	Completed
Phase	N/A
Start date	April 27, 2022
Completion date	December 31, 2022

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT02379520` - HPV-16/18 E6/E7-Specific T Lymphocytes, Relapsed HPV-Associated Cancers, HESTIA	Phase 1
Completed	`NCT02624349` - Immunogenicity and Safety of Human Papilloma Virus Vaccine in Solid Organ Transplant Recipients	Phase 4
Recruiting	`NCT04474821` - HPV Educational Intervention to Increase Acceptance and Completion of Free HPV Vaccination Among Underserved Adults	Phase 4
Withdrawn	`NCT05472220` - Alpelisib in Combination With Carboplatin in Patients With Solid Tumors and HPV-Positive Squamous Cell Carcinoma	Phase 1
Active, not recruiting	`NCT02568566` - Recombinant Human Papillomavirus Nonavalent Vaccine in Preventing Human Papilloma Virus in Younger Healthy Participants	Phase 2
Not yet recruiting	`NCT05985681` - Testing RG1-VLP Vaccine to Prevent HPV-related Cancers	Phase 1
Completed	`NCT04189003` - Molecular Signatures of HPV+ ORL Cancers (OROPAP)
Recruiting	`NCT04927650` - Prevention and Early Detection of Cervical Cancer Through Self-Administered Screening
Completed	`NCT01769560` - MeFirst: A Tailored Intervention to HPV Vaccine Decision Making	N/A
Recruiting	`NCT05831540` - Clinical Decision Support Tools to Increase Human Papillomavirus (HPV) Vaccination in Adolescents in Pharmacies	N/A
Recruiting	`NCT05232851` - A Vaccine (PDS0101) Alone or in Combination With Pembrolizumab for the Treatment of Locally Advanced Human Papillomavirus-Associated Oropharynx Cancer	Phase 1/Phase 2
Active, not recruiting	`NCT04580446` - HYHOPE: De-intensified Hypofractionated Radiation Therapy for HPV-associated Oropharynx Cancer	Phase 1
Active, not recruiting	`NCT03634267` - MRI-Guided Brachytherapy in Treating Participants With HPV-Associated Stage IB2-IVA Cervical or Stage II-IVA Vaginal Cancer	Phase 1
Not yet recruiting	`NCT04142398` - Incidence of HPV Infection and HPV-Associated Disease in Screening Indian Men Who Have Sex With HIV-Positive Men